THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS
MS 自身免疫反应的启动机制
基本信息
- 批准号:7092643
- 负责人:
- 金额:$ 16.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-15 至 2008-07-31
- 项目状态:已结题
- 来源:
- 关键词:CD28 moleculeCHO cellsT cell receptorantigen presenting cellautoimmune disordercellular immunitycentral nervous system disordersclinical researchcross immunityenzyme linked immunosorbent assayexperimental allergic encephalomyelitisgene expressionhelper T lymphocytehuman subjectligandsmultiple sclerosismyelin basic proteinsmyelinopathytissue /cell culturetransfection
项目摘要
DESCRIPTION (provided by applicant): Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS) affecting primarily young adults in their most productive age, and therefore causing a significant disability. While its etiology remains elusive, most evidence supports the autoimmune pathogenesis of the disease. According to this hypothesis, the activation of autoreactive T-cells is a central event in the development of autoimmune response in MS. The objective of this proposal is to examine molecular events involved in the initiation of autoimmune response in MS. Recent studies have reported an unexpectedly high degree of T-cell receptor (TCR) degeneracy and molecular mimicry as a frequent phenomenon that might play a role in the initiation of autoimmune response in MS. MHC DR2-biased combinatorial peptide libraries are developed as a tool to characterize degenerate T-cells. As auto-antigens are predominantly weak TCR ligands, we propose that myelin-reactive T-cells may be over-represented among the cells with a degenerate TCR. Myelin basic protein (MBP)-specific T-cells exhibit decreased CD28 co-stimulatory requirements in MS patients when compared to healthy controls. We hypothesize that dysregulation of co-stimulatory pathways play a role in the initial activation, prolonged survival, and the expansion of autoreactive cells in MS. Co-stimulation-independent activation might be particularly relevant for the autoantigen recognition within the CNS, as local inflammatory environment enhances autoantigen presentation even in the absence of co-stimulatory molecules on the resident antigen presenting cells. We plan to achieve our objective by pursuing the following Specific Aims: 1) Determine the frequency and TCR repertoire of T-cell clonotypes with a high degree of TCR flexibility. 2) Define co-stimulation requirements for the activation and growth characteristics of T-cells with flexible TCR in RR MS patients and OND controls. 3) Identify mechanisms by which the inflammatory environment induces the autoreactive T-cell activation. The information provided by these studies may yield important insights into the physiologic and pathologic role of the autoreactive T cells, and characterize structurally and functionally the specific targets for the new therapies of MS.
描述(由申请人提供):多发性硬化症(MS)是一种中枢神经系统(CNS)的慢性自身免疫性脱髓鞘疾病,主要影响最具生产力年龄的年轻人,因此导致严重残疾。虽然其病因仍然难以捉摸,但大多数证据支持该疾病的自身免疫发病机制。根据这一假设,自身反应性T细胞的激活是MS自身免疫反应发展的中心事件。本研究的目的是检测MS自身免疫反应启动中涉及的分子事件。简并性和分子模拟是一种常见的现象,可能在MS中启动自身免疫反应中发挥作用。开发了偏向的组合肽文库作为表征简并T细胞的工具。由于自身抗原主要是弱TCR配体,我们提出髓鞘反应性T细胞可能在具有退化TCR的细胞中过度表达。与健康对照相比,MS患者中髓鞘碱性蛋白(MBP)特异性T细胞表现出降低的CD28共刺激需求。我们假设,共刺激途径的失调发挥作用的初始激活,延长生存期,并在MS的自身反应性细胞的扩增。共刺激独立的激活可能是特别相关的CNS内的自身抗原识别,因为局部炎症环境增强自身抗原呈递,即使在没有共刺激分子的常驻抗原呈递细胞。我们计划通过追求以下具体目标来实现我们的目标:1)确定具有高度TCR灵活性的T细胞克隆型的频率和TCR库。2)定义RR MS患者和OND对照中具有柔性TCR的T细胞活化和生长特征的共刺激要求。3)确定炎症环境诱导自身反应性T细胞活化的机制。这些研究提供的信息可能会产生重要的见解的生理和病理作用的自身反应性T细胞,并在结构和功能上的MS的新疗法的具体目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Silva Markovic-Plese其他文献
Silva Markovic-Plese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Silva Markovic-Plese', 18)}}的其他基金
Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)
微粒递送的 STING 激动剂在控制实验性自身免疫性脑脊髓炎 (EAE) 和多发性硬化症 (MS) 中的免疫调节作用
- 批准号:
10392967 - 财政年份:2021
- 资助金额:
$ 16.56万 - 项目类别:
The Role of IL-II in the development of autoimmune response in multiple sclerosis
IL-II 在多发性硬化症自身免疫反应发展中的作用
- 批准号:
10221496 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
The Role of IL-II in the development of autoimmune response in multiple sclerosis
IL-II 在多发性硬化症自身免疫反应发展中的作用
- 批准号:
10442499 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
The Role of IL-11 in Development of Th17-mediated Autoimmune Response in EAE
IL-11 在 EAE 中 Th17 介导的自身免疫反应发展中的作用
- 批准号:
8693109 - 财政年份:2014
- 资助金额:
$ 16.56万 - 项目类别:
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS
MS 自身免疫反应的启动机制
- 批准号:
6785871 - 财政年份:2003
- 资助金额:
$ 16.56万 - 项目类别:
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS
MS 自身免疫反应的启动机制
- 批准号:
6602385 - 财政年份:2003
- 资助金额:
$ 16.56万 - 项目类别:
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MS
MS 自身免疫反应的启动机制
- 批准号:
6921316 - 财政年份:2003
- 资助金额:
$ 16.56万 - 项目类别:
THE MECHANISMS OF AUTOIMMUNE RESPONSE INITIATION IN MULTIPLE SCLEROSIS
多发性硬化症中自身免疫反应的启动机制
- 批准号:
7273519 - 财政年份:2003
- 资助金额:
$ 16.56万 - 项目类别:
相似海外基金
Manipulation and engineering of lipid metabolic pathways in CHO cells to enhance processability of cell culture supernantants
CHO 细胞中脂质代谢途径的操作和工程,以增强细胞培养上清液的可加工性
- 批准号:
2873335 - 财政年份:2023
- 资助金额:
$ 16.56万 - 项目类别:
Studentship
Glycoengineering of CHO cells to express recombinant alpha-1 antitrypsin
CHO细胞的糖工程表达重组α-1抗胰蛋白酶
- 批准号:
10484110 - 财政年份:2022
- 资助金额:
$ 16.56万 - 项目类别:
Elucidating the signalling pathways important for antibody production and secretion in CHO cells
阐明 CHO 细胞中抗体产生和分泌的重要信号通路
- 批准号:
2467836 - 财政年份:2020
- 资助金额:
$ 16.56万 - 项目类别:
Studentship
Evaluation of antibody-heterogeneity in CHO cells
CHO 细胞中抗体异质性的评估
- 批准号:
20K15105 - 财政年份:2020
- 资助金额:
$ 16.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Combinatorial approaches to engineer CHO cells to enhance production of difficult-to-express therapeutic proteins
改造 CHO 细胞的组合方法以增强难以表达的治疗性蛋白质的产生
- 批准号:
BB/T508615/1 - 财政年份:2019
- 资助金额:
$ 16.56万 - 项目类别:
Training Grant
Development of rapid production of antibody drugs using a single-copy gene expression system in CHO cells
开发利用 CHO 细胞单拷贝基因表达系统快速生产抗体药物
- 批准号:
19K05178 - 财政年份:2019
- 资助金额:
$ 16.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Utilization of chromosomal instability in CHO cells in recombinant protein production
在重组蛋白生产中利用 CHO 细胞染色体不稳定性
- 批准号:
19K21105 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of a novel inducible expression system for the manufacture of therapeutic proteins from CHO cells.
开发一种新型诱导表达系统,用于从 CHO 细胞生产治疗性蛋白质。
- 批准号:
104199 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
Collaborative R&D
Developing novel biosensors for monitoring antibody production in CHO cells.
开发新型生物传感器来监测 CHO 细胞中抗体的产生。
- 批准号:
1983469 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
Studentship
Cell and Process Engineering for Transient Expression of Recombinant Proteins in CHO Cells
CHO 细胞中重组蛋白瞬时表达的细胞和工艺工程
- 批准号:
2122943 - 财政年份:2018
- 资助金额:
$ 16.56万 - 项目类别:
Studentship